Core Scientific Q1 Validates AI Pivot, but Valuation and Unresolved Risks Push Risk/Reward to Neutral

What happened

Core Scientific's FQ1 2026 results showed colocation revenue surging 801% YoY as the company energized ~350 MW for CoreWeave, proving the AI/HPC pivot is gaining traction. The company expanded power capacity potential to 3 GW, supporting a long-term growth narrative. However, the stock has rallied back to retest prior highs, and at 13.55x EV/Sales, the valuation now reflects much of the optimism. DeepValue analysis continues to flag a material weakness in internal controls over conversion accounting, a 364-day term loan maturing in March 2027, and complete reliance on CoreWeave for colocation revenue. While Q1 de-risks execution to some degree, the near-term risk of refinancing and control remediation still dominates the risk/reward, suggesting investors should wait for better entry points.

Implication

The FQ1 results provide tangible evidence that Core Scientific's conversion of bitcoin mining sites to AI/HPC colocation is on track, with colocation revenue now a meaningful contributor. However, the market has repriced the stock to 13.55x forward sales, near all-time highs, leaving little room for error. Key risks remain: the company must remediate a material weakness in internal controls over PP&E accounting, refinance a $500M term loan maturing in March 2027, and diversify beyond CoreWeave as its sole colocation customer. Without clear progress on these fronts, the current valuation implies execution perfection. A better entry would be below $14, where the risk/reward aligns with the DeepValue bear/base scenario, or after the term loan is extended and control issues are resolved.

Thesis delta

The Q1 results partially de-risk the execution thesis, but the stock's run-up to retest highs has compressed the expected return. The risk/reward has shifted from moderately attractive at $16 to neutral as valuation now prices in the AI pivot without adequate compensation for refinancing and control risks. We maintain a cautious stance until the March 2027 term loan is addressed and the material weakness is remediated.